JP Morgan Private Wealth Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$449K Sell
4,129
-432
-9% -$47.8K ﹤0.01% 1290
2023
Q2
$492K Sell
4,561
-1,065
-19% -$120K ﹤0.01% 1032
2023
Q1
$701K Sell
5,626
-336
-6% -$46.1K ﹤0.01% 1335
2022
Q4
$896K Buy
5,962
+360
+6% +$55.4K ﹤0.01% 1195
2022
Q3
$756K Sell
5,602
-1,191
-18% -$182K ﹤0.01% 1272
2022
Q2
$1.01M Buy
6,793
+117
+2% +$17.9K ﹤0.01% 1146
2022
Q1
$1.14M Buy
6,676
+1,023
+18% +$172K ﹤0.01% 1156
2021
Q4
$1.46M Sell
5,653
-26,862
-83% -$7.36M ﹤0.01% 1062
2021
Q3
$8.88M Buy
32,515
+15,869
+95% +$5.04M 0.02% 454
2021
Q2
$3.73M Buy
16,646
+985
+6% +$186K 0.01% 663
2021
Q1
$1.71M Sell
15,661
-916
-6% -$97.3K 0.01% 820
2020
Q4
$1.35M Buy
16,577
+1,750
+12% +$172K ﹤0.01% 886
2020
Q3
$1.03M Buy
14,827
+4,627
+45% +$332K ﹤0.01% 881
2020
Q2
$681K Buy
+10,200
New +$509K ﹤0.01% 953

Other funds holding BNTX

JP Morgan Private Wealth Advisors's BNTX Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its BioNTech (BNTX) stake by 9.5% in Q3 2023, selling an estimated $47.8K and leaving 4,129 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

JP Morgan Private Wealth Advisors first reported a position in BNTX in Q2 2020 and has held it in 14 quarters since. The position peaked at $8.88M in Q3 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 4,129 shares of BioNTech worth $449K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 432 BioNTech shares in Q3 2023, an estimated $47.8K.
  • BioNTech made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1290 holding.
  • JP Morgan Private Wealth Advisors first reported a position in BioNTech in Q2 2020 and has held it in 14 quarters since.
  • JP Morgan Private Wealth Advisors's BioNTech position peaked at $8.88M in Q3 2021.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.